| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.804 | 0.005 | 0.804 | Analgesic | 0.759 0.008 CID_9816910 0.739 0.01 CID_9881925 0.347 0.11 CID_154699717 | ||
| 0.771 | 0.004 | 0.783 | Psychostimulant | 0.783 0.004 CID_9816910 0.675 0.005 CID_9881925 0.387 0.025 CID_154699717 | CID_9816910 | |
| 0.758 | 0.003 | 0.758 | 5 Hydroxytryptamine uptake inhibitor | 0.641 0.004 CID_9816910 0.678 0.003 CID_9881925 0.518 0.004 CID_154699717 | ||
| 0.625 | 0.004 | 0.632 | Calcium channel L-type activator | 0.617 0.005 CID_9816910 0.632 0.004 CID_9881925 0.494 0.03 CID_154699717 | CID_9881925 | |
| 0.622 | 0.003 | 0.622 | Adrenaline uptake inhibitor | 0.504 0.003 CID_9816910 0.527 0.003 CID_9881925 0.371 0.004 CID_154699717 | ||
| 0.566 | 0.009 | 0.597 | Vasodilator, coronary | 0.592 0.008 CID_9816910 0.597 0.008 CID_9881925 0.359 0.051 CID_154699717 | CID_9881925 | |
| 0.421 | 0.002 | 0.421 | Toll-Like receptor 3 antagonist | 0.342 0.003 CID_9816910 0.386 0.003 CID_9881925 0.223 0.005 CID_154699717 | ||
| 0.418 | 0.004 | 0.418 | 5 Hydroxytryptamine 1E antagonist | 0.386 0.005 CID_9816910 0.313 0.022 CID_9881925 0.253 0.072 CID_154699717 | ||
| 0.444 | 0.037 | 0.444 | 5 Hydroxytryptamine release stimulant | 0.396 0.047 CID_9816910 0.442 0.038 CID_9881925 0.188 0.132 CID_154699717 | ||
| 0.417 | 0.019 | 0.417 | Calcium channel activator | 0.403 0.023 CID_9816910 0.385 0.031 CID_9881925 0.259 0.137 CID_154699717 | ||
| 0.386 | 0.005 | 0.386 | Alpha 2b adrenoreceptor antagonist | 0.313 0.008 CID_9816910 0.201 0.023 CID_9881925 | ||
| 0.376 | 0.008 | 0.385 | Anesthetic local | 0.343 0.009 CID_9816910 0.385 0.007 CID_9881925 0.131 0.059 CID_154699717 | CID_9881925 | |
| 0.365 | 0.004 | 0.365 | Inducible nitric-oxide synthase inhibitor | 0.312 0.004 CID_9816910 0.219 0.007 CID_9881925 0.186 0.01 CID_154699717 | ||
| 0.4 | 0.064 | 0.527 | Transcription factor NF kappa B inhibitor | 0.527 0.04 CID_9816910 0.462 0.05 CID_9881925 0.363 0.073 CID_154699717 | CID_9816910 | |
| 0.393 | 0.057 | 0.427 | Vasodilator, peripheral | 0.419 0.049 CID_9816910 0.427 0.047 CID_9881925 0.259 0.12 CID_154699717 | CID_9881925 | |
| 0.419 | 0.085 | 0.419 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.288 0.23 CID_9816910 0.281 0.239 CID_9881925 | ||
| 0.361 | 0.028 | 0.436 | Anticonvulsant | 0.205 0.079 CID_9816910 0.28 0.046 CID_9881925 0.436 0.018 CID_154699717 | CID_154699717 | |
| 0.336 | 0.004 | 0.336 | Nitric-oxide synthase inhibitor | 0.269 0.005 CID_9816910 0.222 0.007 CID_9881925 0.151 0.022 CID_154699717 | ||
| 0.343 | 0.013 | 0.346 | Peptidyltransferase inhibitor | 0.346 0.013 CID_9816910 0.337 0.014 CID_9881925 0.275 0.036 CID_154699717 | CID_9816910 | |
| 0.36 | 0.05 | 0.472 | Spasmolytic | 0.425 0.035 CID_9816910 0.472 0.027 CID_9881925 0.285 0.076 CID_154699717 | CID_9881925 | |
| 0.337 | 0.042 | 0.451 | Antiamyloidogenic | 0.447 0.022 CID_9816910 0.319 0.046 CID_9881925 0.451 0.021 CID_154699717 | CID_154699717 | |
| 0.369 | 0.078 | 0.387 | Antiobesity | 0.296 0.119 CID_9816910 0.387 0.071 CID_9881925 | CID_9881925 | |
| 0.297 | 0.014 | 0.297 | Antiadrenergic | 0.226 0.02 CID_9816910 0.237 0.019 CID_9881925 0.124 0.044 CID_154699717 | ||
| 0.29 | 0.014 | 0.29 | Adrenaline antagonist | 0.22 0.02 CID_9816910 0.232 0.019 CID_9881925 0.121 0.043 CID_154699717 | ||
| 0.271 | 0.008 | 0.271 | Alpha 2c adrenoreceptor antagonist | 0.227 0.013 CID_9816910 0.231 0.013 CID_9881925 | ||
| 0.262 | 0.02 | 0.262 | 5 Hydroxytryptamine 2 antagonist | 0.162 0.04 CID_9816910 0.171 0.038 CID_9881925 | ||
| 0.292 | 0.052 | 0.393 | Interleukin agonist | 0.302 0.047 CID_9816910 0.393 0.02 CID_9881925 0.208 0.114 CID_154699717 | CID_9881925 | |
| 0.291 | 0.051 | 0.349 | Vasodilator | 0.309 0.045 CID_9816910 0.313 0.044 CID_9881925 0.349 0.033 CID_154699717 | CID_154699717 | |
| 0.288 | 0.053 | 0.288 | Ca(v)3.3 blocker | 0.236 0.123 CID_9816910 0.211 0.169 CID_154699717 | ||
| 0.229 | 0.005 | 0.229 | Dopamine uptake inhibitor | 0.164 0.009 CID_9816910 0.15 0.01 CID_9881925 0.101 0.018 CID_154699717 | ||
| 0.242 | 0.02 | 0.242 | 5 Hydroxytryptamine 3E antagonist | 0.179 0.108 CID_9816910 0.19 0.081 CID_9881925 | ||
| 0.227 | 0.005 | 0.387 | Adrenaline agonist | 0.299 0.004 CID_9816910 0.387 0.003 CID_9881925 0.161 0.012 CID_154699717 | CID_9881925 | |
| 0.246 | 0.026 | 0.246 | Antipruritic | 0.235 0.03 CID_9816910 0.157 0.086 CID_9881925 | ||
| 0.24 | 0.028 | 0.259 | Acetylcholine M1 receptor antagonist | 0.231 0.03 CID_9816910 0.259 0.023 CID_9881925 0.133 0.092 CID_154699717 | CID_9881925 | |
| 0.217 | 0.007 | 0.217 | Alpha adrenoreceptor agonist | 0.2 0.009 CID_9816910 0.171 0.013 CID_9881925 0.06 0.055 CID_154699717 | ||
| 0.221 | 0.015 | 0.221 | Interleukin 1b antagonist | 0.181 0.024 CID_9816910 0.176 0.026 CID_9881925 0.125 0.058 CID_154699717 | ||
| 0.214 | 0.015 | 0.214 | Alpha 2 adrenoreceptor antagonist | 0.161 0.024 CID_9816910 0.168 0.023 CID_9881925 | ||
| 0.346 | 0.149 | 0.403 | Caspase 9 stimulant | 0.403 0.109 CID_9816910 0.377 0.125 CID_9881925 | CID_9816910 | |
| 0.207 | 0.011 | 0.25 | Adenylate cyclase stimulant | 0.233 0.005 CID_9816910 0.25 0.004 CID_9881925 0.157 0.052 CID_154699717 | CID_9881925 | |
| 0.289 | 0.099 | 0.345 | Cholesterol antagonist | 0.34 0.069 CID_9816910 0.345 0.066 CID_9881925 0.22 0.148 CID_154699717 | CID_9881925 | |
| 0.202 | 0.017 | 0.202 | 5 Hydroxytryptamine 1 antagonist | 0.104 0.036 CID_9816910 0.085 0.044 CID_9881925 | ||
| 0.19 | 0.004 | 0.254 | Beta adrenoreceptor antagonist | 0.252 0.003 CID_9816910 0.254 0.003 CID_9881925 0.163 0.005 CID_154699717 | CID_9881925 | |
| 0.211 | 0.026 | 0.211 | Alpha adrenoreceptor antagonist | 0.142 0.04 CID_9816910 0.111 0.051 CID_9881925 | ||
| 0.296 | 0.119 | 0.296 | GABA C receptor rho-3 antagonist | 0.295 0.119 CID_9816910 | ||
| 0.196 | 0.02 | 0.196 | 5 Hydroxytryptamine 2A antagonist | 0.113 0.041 CID_9816910 0.104 0.045 CID_9881925 | ||
| 0.321 | 0.145 | 0.428 | Cyclophilin D inhibitor | 0.351 0.121 CID_9816910 0.428 0.076 CID_9881925 | CID_9881925 | |
| 0.245 | 0.073 | 0.302 | Tyrosine 3 hydroxylase inhibitor | 0.302 0.032 CID_9816910 0.231 0.088 CID_9881925 0.232 0.088 CID_154699717 | CID_9816910 | |
| 0.251 | 0.08 | 0.251 | 5 Hydroxytryptamine uptake stimulant | 0.241 0.09 CID_9816910 0.238 0.093 CID_9881925 0.201 0.151 CID_154699717 | ||
| 0.184 | 0.016 | 0.184 | Alpha 2a adrenoreceptor antagonist | 0.15 0.022 CID_9816910 0.102 0.035 CID_9881925 | ||
| 0.293 | 0.127 | 0.346 | Histamine release inhibitor | 0.346 0.102 CID_9816910 0.282 0.134 CID_9881925 | CID_9816910 | |
| 0.18 | 0.014 | 0.215 | Sphingomyelinase inhibitor | 0.163 0.02 CID_9816910 0.215 0.007 CID_9881925 0.16 0.02 CID_154699717 | CID_9881925 | |
| 0.244 | 0.08 | 0.312 | Hypoglycemic | 0.295 0.054 CID_9816910 0.312 0.049 CID_9881925 0.202 0.11 CID_154699717 | CID_9881925 | |
| 0.198 | 0.034 | 0.198 | 5 Hydroxytryptamine antagonist | 0.099 0.08 CID_9816910 0.094 0.084 CID_9881925 | ||
| 0.166 | 0.004 | 0.209 | Beta 1 adrenoreceptor antagonist | 0.209 0.003 CID_9816910 0.208 0.003 CID_9881925 0.107 0.009 CID_154699717 | CID_9816910 | |
| 0.163 | 0.004 | 0.163 | Glycine transporter 1 inhibitor | 0.107 0.005 CID_9816910 0.115 0.005 CID_9881925 0.087 0.007 CID_154699717 | ||
| 0.171 | 0.013 | 0.171 | 5 Hydroxytryptamine 1F antagonist | 0.111 0.027 CID_9816910 0.099 0.032 CID_9881925 | ||
| 0.178 | 0.021 | 0.178 | 5 Hydroxytryptamine 2C antagonist | 0.108 0.041 CID_9816910 0.08 0.061 CID_9881925 | ||
| 0.212 | 0.062 | 0.244 | Insulin sensitizer | 0.23 0.048 CID_9816910 0.244 0.038 CID_9881925 0.192 0.081 CID_154699717 | CID_9881925 | |
| 0.307 | 0.157 | 0.307 | 5 Hydroxytryptamine release inhibitor | 0.307 0.157 CID_9816910 0.242 0.24 CID_9881925 0.273 0.197 CID_154699717 | ||
| 0.169 | 0.019 | 0.254 | NMDA receptor antagonist | 0.254 0.009 CID_9816910 0.136 0.029 CID_9881925 0.091 0.053 CID_154699717 | CID_9816910 | |
| 0.208 | 0.059 | 0.217 | P-glycoprotein inhibitor | 0.217 0.055 CID_9816910 0.207 0.06 CID_9881925 | CID_9816910 | |
| 0.174 | 0.026 | 0.174 | Antihistaminic | 0.083 0.073 CID_9816910 0.1 0.055 CID_9881925 | ||
| 0.157 | 0.01 | 0.157 | Glutamate (mGluR7) agonist | 0.122 0.029 CID_9816910 0.136 0.018 CID_9881925 | ||
| 0.213 | 0.069 | 0.235 | Nitric-oxide synthase stimulant | 0.232 0.047 CID_9816910 0.235 0.044 CID_9881925 0.189 0.108 CID_154699717 | CID_9881925 | |
| 0.158 | 0.014 | 0.158 | Protein kinase B gamma inhibitor | 0.109 0.029 CID_9816910 0.133 0.021 CID_9881925 | ||
| 0.159 | 0.019 | 0.159 | 5 Hydroxytryptamine 1A antagonist | 0.088 0.036 CID_9816910 0.07 0.046 CID_9881925 | ||
| 0.143 | 0.005 | 0.199 | Beta 2 adrenoreceptor antagonist | 0.198 0.004 CID_9816910 0.199 0.003 CID_9881925 0.085 0.01 CID_154699717 | CID_9881925 | |
| 0.142 | 0.006 | 0.142 | Dopamine transporter inhibitor | 0.108 0.01 CID_9816910 0.101 0.012 CID_9881925 0.096 0.013 CID_154699717 | ||
| 0.205 | 0.072 | 0.259 | Neurotrophic factor enhancer | 0.259 0.034 CID_9816910 0.217 0.062 CID_9881925 | CID_9816910 | |
| 0.16 | 0.027 | 0.16 | Histamine antagonist | 0.088 0.056 CID_9881925 | ||
| 0.175 | 0.044 | 0.175 | Interleukin 1 antagonist | 0.154 0.055 CID_9816910 0.126 0.08 CID_9881925 0.123 0.085 CID_154699717 | ||
| 0.173 | 0.043 | 0.173 | Calcium channel blocker | 0.112 0.097 CID_9816910 | ||
| 0.175 | 0.045 | 0.175 | Nav1.2 sodium channel blocker | 0.128 0.075 CID_9816910 | ||
| 0.139 | 0.009 | 0.139 | Acetylcholine M5 receptor antagonist | 0.111 0.015 CID_9816910 0.138 0.009 CID_9881925 | ||
| 0.15 | 0.022 | 0.15 | Alpha 1b adrenoreceptor antagonist | 0.097 0.036 CID_9816910 0.061 0.06 CID_9881925 | ||
| 0.162 | 0.036 | 0.162 | 5 Hydroxytryptamine 2B antagonist | 0.12 0.06 CID_9816910 0.111 0.07 CID_9881925 | ||
| 0.206 | 0.081 | 0.255 | Interleukin antagonist | 0.255 0.06 CID_9816910 0.197 0.086 CID_9881925 | CID_9816910 | |
| 0.22 | 0.095 | 0.446 | Aldehyde oxidase inhibitor | 0.446 0.04 CID_9816910 0.161 0.13 CID_154699717 | CID_9816910 | |
| 0.171 | 0.05 | 0.171 | Toll-Like receptor 9 antagonist | 0.112 0.095 CID_9816910 | ||
| 0.147 | 0.03 | 0.147 | Alpha 1 adrenoreceptor antagonist | 0.088 0.048 CID_9816910 | ||
| 0.124 | 0.008 | 0.124 | Glycine transporter inhibitor | 0.073 0.019 CID_9816910 0.066 0.022 CID_9881925 | ||
| 0.194 | 0.078 | 0.255 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.255 0.04 CID_9816910 0.199 0.073 CID_9881925 0.156 0.136 CID_154699717 | CID_9816910 | |
| 0.155 | 0.041 | 0.179 | Acetylcholine muscarinic antagonist | 0.156 0.04 CID_9816910 0.179 0.031 CID_9881925 | CID_9881925 | |
| 0.122 | 0.01 | 0.122 | Alpha 2 adrenoreceptor agonist | 0.103 0.014 CID_9816910 0.097 0.016 CID_9881925 | ||
| 0.175 | 0.064 | 0.192 | ATPase inhibitor | 0.192 0.044 CID_9816910 | CID_9816910 | |
| 0.149 | 0.039 | 0.172 | Vanilloid 1 agonist | 0.172 0.022 CID_9816910 0.144 0.045 CID_9881925 0.131 0.065 CID_154699717 | CID_9816910 | |
| 0.127 | 0.018 | 0.168 | Glutamate release inhibitor | 0.1 0.043 CID_9816910 0.168 0.007 CID_9881925 | CID_9881925 | |
| 0.122 | 0.012 | 0.122 | Alpha 1 adrenoreceptor agonist | 0.096 0.018 CID_9816910 0.06 0.036 CID_9881925 | ||
| 0.134 | 0.025 | 0.134 | Acetylcholine nicotinic antagonist | 0.103 0.037 CID_9816910 0.119 0.03 CID_9881925 | ||
| 0.153 | 0.046 | 0.153 | Nav1.3 sodium channel blocker | 0.11 0.086 CID_9816910 | ||
| 0.211 | 0.109 | 0.211 | Cardiotonic | 0.175 0.145 CID_9816910 | ||
| 0.109 | 0.008 | 0.109 | Factor IXa inhibitor | 0.1 0.01 CID_9816910 0.101 0.01 CID_9881925 0.096 0.011 CID_154699717 | ||
| 0.108 | 0.013 | 0.142 | Beta 3 adrenoreceptor antagonist | 0.142 0.007 CID_9816910 0.12 0.01 CID_9881925 0.066 0.04 CID_154699717 | CID_9816910 | |
| 0.133 | 0.038 | 0.366 | Bronchodilator | 0.155 0.03 CID_9816910 0.366 0.006 CID_9881925 | CID_9881925 | |
| 0.133 | 0.04 | 0.133 | Nav1.5 sodium channel blocker | 0.101 0.083 CID_9816910 0.115 0.061 CID_9881925 | ||
| 0.113 | 0.02 | 0.113 | Alpha 1d adrenoreceptor antagonist | 0.063 0.038 CID_9816910 | ||
| 0.147 | 0.054 | 0.173 | Cholinergic antagonist | 0.141 0.058 CID_9816910 0.173 0.041 CID_9881925 | CID_9881925 | |
| 0.146 | 0.057 | 0.146 | Acetylcholinesterase inhibitor | 0.138 0.063 CID_9816910 0.109 0.091 CID_9881925 | ||
| 0.214 | 0.127 | 0.328 | Lipoxygenase inhibitor | 0.328 0.058 CID_9816910 0.182 0.16 CID_9881925 0.248 0.102 CID_154699717 | CID_9816910 | |
| 0.141 | 0.055 | 0.168 | Acetylcholine antagonist | 0.135 0.059 CID_9816910 0.168 0.041 CID_9881925 | CID_9881925 | |
| 0.145 | 0.059 | 0.145 | Nav1.6 sodium channel blocker | 0.123 0.091 CID_9816910 | ||
| 0.213 | 0.129 | 0.213 | Gastrin inhibitor | |||
| 0.125 | 0.041 | 0.127 | Electron transport complex I inhibitor | 0.127 0.038 CID_9816910 0.098 0.087 CID_9881925 0.105 0.072 CID_154699717 | CID_9816910 | |
| 0.125 | 0.041 | 0.143 | Urease inhibitor | 0.143 0.027 CID_9816910 | CID_9816910 | |
| 0.143 | 0.064 | 0.143 | Ca2+-transporting ATPase inhibitor | 0.141 0.069 CID_9816910 0.135 0.096 CID_9881925 0.139 0.076 CID_154699717 | ||
| 0.116 | 0.037 | 0.116 | Calcium antagonist | |||
| 0.123 | 0.044 | 0.123 | Acetylcholine release stimulant | 0.108 0.069 CID_9881925 | ||
| 0.119 | 0.041 | 0.131 | Anabolic | 0.131 0.03 CID_9816910 0.12 0.039 CID_9881925 0.101 0.062 CID_154699717 | CID_9816910 | |
| 0.106 | 0.03 | 0.106 | Histamine H2 receptor antagonist | 0.085 0.055 CID_9816910 | ||
| 0.1 | 0.025 | 0.171 | Phenylalanine 4-hydroxylase inhibitor | 0.171 0.009 CID_9816910 0.118 0.019 CID_9881925 | CID_9816910 | |
| 0.124 | 0.05 | 0.176 | Mucolytic | 0.141 0.038 CID_9816910 0.176 0.02 CID_9881925 0.125 0.05 CID_154699717 | CID_9881925 | |
| 0.098 | 0.025 | 0.098 | Neuronal nicotinic receptor antagonist | 0.078 0.038 CID_9816910 0.088 0.03 CID_9881925 | ||
| 0.136 | 0.063 | 0.136 | Sphingosine 1-phosphate receptor 2 antagonist | 0.134 0.066 CID_9816910 0.132 0.07 CID_154699717 | ||
| 0.18 | 0.11 | 0.193 | Hypolipemic | 0.193 0.1 CID_9816910 0.168 0.12 CID_9881925 0.155 0.132 CID_154699717 | CID_9816910 | |
| 0.143 | 0.073 | 0.192 | Protein kinase stimulant | 0.192 0.045 CID_9816910 0.186 0.047 CID_9881925 | CID_9816910 | |
| 0.138 | 0.069 | 0.177 | Farnesoid X receptor antagonist | 0.177 0.031 CID_9816910 0.123 0.096 CID_154699717 | CID_9816910 | |
| 0.097 | 0.028 | 0.122 | Estrogen-related receptor beta agonist | 0.122 0.009 CID_9816910 0.089 0.042 CID_9881925 0.082 0.062 CID_154699717 | CID_9816910 | |
| 0.09 | 0.021 | 0.163 | Acetylcholine M3 receptor antagonist | 0.115 0.015 CID_9816910 0.163 0.01 CID_9881925 | CID_9881925 | |
| 0.077 | 0.011 | 0.137 | Beta 2 adrenoreceptor agonist | 0.095 0.005 CID_9816910 0.137 0.003 CID_9881925 0.068 0.023 CID_154699717 | CID_9881925 | |
| 0.088 | 0.022 | 0.088 | Carbonic anhydrase stimulant | 0.076 0.028 CID_9816910 0.062 0.038 CID_9881925 | ||
| 0.127 | 0.062 | 0.199 | Alkylator | 0.143 0.05 CID_9816910 0.199 0.027 CID_9881925 0.127 0.062 CID_154699717 | CID_9881925 | |
| 0.068 | 0.003 | 0.068 | Alpha 2a adrenoreceptor agonist | 0.061 0.004 CID_9816910 0.016 0.014 CID_9881925 | ||
| 0.086 | 0.022 | 0.086 | Potassium channel (Tandem pore domain) blocker | |||
| 0.163 | 0.101 | 0.186 | Anesthetic general | 0.186 0.082 CID_9816910 0.166 0.098 CID_9881925 | CID_9816910 | |
| 0.129 | 0.068 | 0.129 | Antibacterial (Helicobacter pylori) | 0.127 0.071 CID_9816910 0.107 0.104 CID_9881925 | ||
| 0.22 | 0.162 | 0.312 | Sodium/bile acid cotransporter inhibitor | 0.312 0.069 CID_9816910 0.218 0.164 CID_9881925 0.221 0.161 CID_154699717 | CID_9816910 | |
| 0.145 | 0.088 | 0.194 | Melanin inhibitor | 0.194 0.043 CID_9816910 0.135 0.105 CID_9881925 0.144 0.091 CID_154699717 | CID_9816910 | |
| 0.088 | 0.032 | 0.088 | Calcium channel L-type blocker | |||
| 0.11 | 0.053 | 0.11 | Gastric antisecretory | 0.097 0.07 CID_9816910 | ||
| 0.171 | 0.115 | 0.171 | Potassium channel blocker | |||
| 0.142 | 0.086 | 0.142 | GABA C receptor rho-2 antagonist | 0.132 0.102 CID_9816910 | ||
| 0.084 | 0.029 | 0.084 | 5 Hydroxytryptamine 1D antagonist | |||
| 0.1 | 0.046 | 0.102 | Polo-like kinase-1 inhibitor | 0.087 0.068 CID_9816910 0.102 0.043 CID_9881925 | CID_9881925 | |
| 0.093 | 0.039 | 0.093 | CYP2A6 inhibitor | |||
| 0.079 | 0.026 | 0.079 | TRPA1 antagonist | 0.069 0.033 CID_9816910 | ||
| 0.116 | 0.063 | 0.139 | TRPA1 agonist | 0.139 0.039 CID_9816910 | CID_9816910 | |
| 0.061 | 0.009 | 0.061 | Diamine oxidase inhibitor | 0.041 0.022 CID_9816910 0.053 0.013 CID_9881925 | ||
| 0.066 | 0.017 | 0.123 | NMDA receptor subunit 3B antagonist | 0.123 0.008 CID_9816910 0.049 0.026 CID_9881925 | CID_9816910 | |
| 0.06 | 0.011 | 0.06 | Alpha 1d adrenoreceptor agonist | 0.056 0.013 CID_9816910 | ||
| 0.106 | 0.063 | 0.164 | Expectorant | 0.129 0.045 CID_9816910 0.164 0.03 CID_9881925 0.098 0.071 CID_154699717 | CID_9881925 | |
| 0.085 | 0.042 | 0.085 | Alpha 1a adrenoreceptor antagonist | |||
| 0.08 | 0.037 | 0.08 | Sphingosine 1-phosphate receptor 4 agonist | 0.065 0.049 CID_9881925 | ||
| 0.059 | 0.017 | 0.103 | NMDA receptor subunit 3A antagonist | 0.103 0.008 CID_9816910 0.04 0.025 CID_9881925 | CID_9816910 | |
| 0.197 | 0.155 | 0.262 | Hypoxia-inducible factor 1 alpha inhibitor | 0.262 0.09 CID_9816910 0.217 0.133 CID_9881925 | CID_9816910 | |
| 0.208 | 0.167 | 0.314 | Antithrombotic | 0.233 0.141 CID_9816910 0.314 0.079 CID_9881925 | CID_9881925 | |
| 0.119 | 0.078 | 0.131 | Cyclooxygenase 3 inhibitor | 0.131 0.065 CID_9816910 0.115 0.083 CID_9881925 | CID_9816910 | |
| 0.064 | 0.023 | 0.092 | Glycine transporter 2 inhibitor | 0.092 0.014 CID_9816910 0.061 0.025 CID_9881925 | CID_9816910 | |
| 0.054 | 0.018 | 0.054 | Histamine H2 receptor agonist | |||
| 0.079 | 0.043 | 0.079 | Vanilloid 4 agonist | 0.071 0.06 CID_9881925 | ||
| 0.055 | 0.019 | 0.075 | Cytokine production stimulant | 0.075 0.005 CID_9881925 | CID_9881925 | |
| 0.05 | 0.014 | 0.05 | Nociceptin (N/OFQ) receptor antagonist | 0.042 0.019 CID_9816910 | ||
| 0.104 | 0.07 | 0.115 | Nav1.4 sodium channel blocker | 0.115 0.057 CID_9816910 0.101 0.075 CID_9881925 0.093 0.087 CID_154699717 | CID_9816910 | |
| 0.099 | 0.065 | 0.16 | 5-Lipoxygenase inhibitor | 0.16 0.034 CID_9816910 | CID_9816910 | |
| 0.109 | 0.075 | 0.109 | Microtubule formation inhibitor | 0.109 0.075 CID_9816910 | ||
| 0.051 | 0.017 | 0.1 | Beta adrenoreceptor agonist | 0.066 0.006 CID_9816910 0.1 0.004 CID_9881925 0.046 0.03 CID_154699717 | CID_9881925 | |
| 0.13 | 0.096 | 0.13 | Cholinergic | |||
| 0.038 | 0.004 | 0.038 | Alpha 2c adrenoreceptor agonist | 0.02 0.01 CID_9816910 0.021 0.01 CID_9881925 | ||
| 0.094 | 0.061 | 0.129 | Prolactin inhibitor | 0.129 0.033 CID_9816910 0.094 0.062 CID_9881925 | CID_9816910 | |
| 0.119 | 0.086 | 0.119 | Sodium channel (voltage-gated) blocker | |||
| 0.109 | 0.076 | 0.155 | Adenylate cyclase inhibitor | 0.136 0.055 CID_9816910 0.155 0.042 CID_9881925 | CID_9881925 | |
| 0.099 | 0.068 | 0.107 | Nav1.1 sodium channel blocker | 0.101 0.065 CID_9816910 0.107 0.059 CID_9881925 | CID_9881925 | |
| 0.036 | 0.005 | 0.036 | 1,3-Beta-glucan synthase inhibitor | 0.036 0.005 CID_9816910 0.036 0.005 CID_9881925 0.033 0.008 CID_154699717 | ||
| 0.097 | 0.067 | 0.097 | GABA C receptor rho-1 antagonist | 0.087 0.084 CID_9816910 | ||
| 0.094 | 0.065 | 0.097 | Lanosterol 14 alpha demethylase inhibitor | 0.097 0.06 CID_9881925 | CID_9881925 | |
| 0.087 | 0.059 | 0.103 | Ornithine decarboxylase inhibitor | 0.096 0.049 CID_9816910 0.103 0.041 CID_9881925 | CID_9881925 | |
| 0.171 | 0.144 | 0.263 | DNA damaging | 0.175 0.14 CID_9816910 0.263 0.073 CID_9881925 0.176 0.139 CID_154699717 | CID_9881925 | |
| 0.048 | 0.022 | 0.048 | Histamine H1 receptor agonist | |||
| 0.057 | 0.031 | 0.057 | 5 Hydroxytryptamine 1B agonist | |||
| 0.048 | 0.028 | 0.048 | Histamine H3 receptor antagonist | |||
| 0.083 | 0.063 | 0.104 | Vanilloid agonist | 0.104 0.029 CID_9816910 | CID_9816910 | |
| 0.025 | 0.005 | 0.025 | Alpha 2b adrenoreceptor agonist | 0.018 0.016 CID_9816910 0.019 0.013 CID_9881925 | ||
| 0.153 | 0.134 | 0.153 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.029 | 0.01 | 0.029 | Acid ceramidase inhibitor | 0.024 0.023 CID_9881925 | ||
| 0.026 | 0.008 | 0.026 | Factor IX inhibitor | 0.019 0.012 CID_9816910 0.021 0.011 CID_9881925 0.017 0.014 CID_154699717 | ||
| 0.048 | 0.031 | 0.048 | Benzodiazepine antagonist | |||
| 0.038 | 0.021 | 0.055 | Ceramide glucosyltransferase inhibitor | 0.033 0.029 CID_9816910 0.055 0.005 CID_9881925 | CID_9881925 | |
| 0.062 | 0.045 | 0.062 | 5 Hydroxytryptamine 2A agonist | 0.056 0.051 CID_9816910 | ||
| 0.09 | 0.074 | 0.104 | Bile acid receptor antagonist | 0.104 0.041 CID_9816910 | CID_9816910 | |
| 0.189 | 0.174 | 0.207 | Insulysin inhibitor | 0.207 0.146 CID_9816910 | CID_9816910 | |
| 0.03 | 0.015 | 0.039 | Estrogen-related receptor gamma antagonist | 0.039 0.005 CID_9816910 0.029 0.017 CID_9881925 | CID_9816910 | |
| 0.025 | 0.01 | 0.025 | Imidazoline I1 receptor antagonist | |||
| 0.118 | 0.103 | 0.176 | Cell wall synthesis inhibitor | 0.129 0.088 CID_9816910 0.176 0.043 CID_9881925 0.173 0.045 CID_154699717 | CID_9881925 | |
| 0.05 | 0.035 | 0.053 | Squalene epoxidase inhibitor | 0.053 0.029 CID_9816910 0.052 0.031 CID_9881925 | CID_9816910 | |
| 0.114 | 0.099 | 0.13 | Papain-like protease (SARS coronavirus) inhibitor | 0.13 0.06 CID_9816910 | CID_9816910 | |
| 0.051 | 0.037 | 0.051 | 5 Hydroxytryptamine 2 agonist | |||
| 0.062 | 0.049 | 0.062 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.027 | 0.014 | 0.03 | Vanilloid 2 agonist | 0.03 0.01 CID_9816910 0.024 0.021 CID_9881925 | CID_9816910 | |
| 0.096 | 0.084 | 0.096 | GABA C receptor antagonist | 0.093 0.089 CID_9816910 | ||
| 0.046 | 0.034 | 0.046 | Potassium channel Kv1.3 blocker | 0.043 0.037 CID_9816910 | ||
| 0.088 | 0.077 | 0.088 | Alpha 2d adrenoreceptor antagonist | |||
| 0.044 | 0.034 | 0.044 | Parathyroid hormone antagonist | |||
| 0.091 | 0.081 | 0.091 | Ferrochelatase inhibitor | |||
| 0.031 | 0.02 | 0.031 | Lysophosphatidic acid 2 receptor antagonist | 0.029 0.023 CID_154699717 | ||
| 0.02 | 0.01 | 0.03 | Estrogen-related receptor gamma agonist | 0.03 0.004 CID_9816910 | CID_9816910 | |
| 0.014 | 0.005 | 0.014 | Imidazoline I2 receptor antagonist | |||
| 0.048 | 0.039 | 0.048 | Alpha 1b adrenoreceptor agonist | 0.047 0.045 CID_9816910 | ||
| 0.068 | 0.059 | 0.068 | Peroxisome proliferator-activated receptor gamma antagonist | 0.068 0.06 CID_9816910 | ||
| 0.073 | 0.065 | 0.105 | Interferon agonist | 0.105 0.025 CID_9881925 | CID_9881925 | |
| 0.061 | 0.055 | 0.061 | Calcium channel P-type blocker | |||
| 0.196 | 0.191 | 0.196 | Calpain 2 inhibitor | |||
| 0.024 | 0.02 | 0.024 | Lysophosphatidic acid receptor 1 agonist | 0.024 0.02 CID_9881925 | ||
| 0.051 | 0.047 | 0.051 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.038 | 0.035 | 0.039 | Sphingosine 1-phosphate receptor 1 agonist | 0.039 0.033 CID_9881925 0.039 0.033 CID_154699717 | CID_154699717 | |
| 0.02 | 0.017 | 0.02 | Lysophosphatidic acid 1 receptor antagonist | |||
| 0.08 | 0.078 | 0.108 | Aminoacyl-tRNA synthetase inhibitor | 0.087 0.064 CID_9816910 0.108 0.038 CID_9881925 | CID_9881925 | |
| 0.083 | 0.081 | 0.085 | ABCA1 expression enhancer | 0.085 0.075 CID_9816910 | CID_9816910 | |
| 0.031 | 0.029 | 0.033 | Melatonin receptor 1A agonist | 0.033 0.023 CID_9881925 | CID_9881925 | |
| 0.02 | 0.019 | 0.025 | Leukotriene B4 receptor 2 antagonist | 0.022 0.016 CID_9816910 0.025 0.013 CID_9881925 | CID_9881925 | |
| 0.036 | 0.035 | 0.036 | Glutamate (mGluR1a) antagonist | |||
| 0.096 | 0.096 | 0.1 | Photosensitizer | 0.098 0.092 CID_9816910 0.1 0.09 CID_9881925 | CID_9881925 | |
| 0.058 | 0.059 | 0.081 | Interferon inducer | 0.081 0.023 CID_9881925 | CID_9881925 | |
| 0.048 | 0.049 | 0.075 | Alpha-mannosidase inhibitor | 0.049 0.046 CID_9816910 0.075 0.014 CID_9881925 | CID_9881925 | |
| 0.078 | 0.08 | 0.11 | Triose-phosphate isomerase inhibitor | 0.11 0.039 CID_9881925 0.086 0.065 CID_154699717 | CID_9881925 | |
| 0.097 | 0.1 | 0.102 | Glutamate receptor antagonist | 0.102 0.094 CID_9816910 | CID_9816910 | |
| 0.02 | 0.022 | 0.04 | Beta 1 adrenoreceptor agonist | 0.028 0.009 CID_9816910 0.04 0.005 CID_9881925 | CID_9881925 | |
| 0.042 | 0.045 | 0.059 | NMDA 2A receptor antagonist | 0.059 0.03 CID_9816910 | CID_9816910 | |
| 0.049 | 0.053 | 0.05 | Epithelial sodium channel blocker | 0.05 0.049 CID_9881925 | CID_9881925 | |
| 0.043 | 0.049 | 0.047 | Lysophosphatidic acid 3 receptor antagonist | 0.047 0.04 CID_9881925 | CID_9881925 | |
| 0.036 | 0.044 | 0.039 | Sphingosine 1-phosphate receptor agonist | 0.039 0.038 CID_9881925 | CID_9881925 | |
| 0.06 | 0.069 | 0.067 | Aminopeptidase I inhibitor | 0.067 0.058 CID_154699717 | CID_154699717 | |
| 0.043 | 0.053 | 0.056 | Acyl-CoA dehydrogenase inhibitor | 0.056 0.036 CID_9881925 | CID_9881925 | |
| 0.021 | 0.032 | 0.043 | Glucagon receptor antagonist | 0.043 0.012 CID_9881925 | CID_9881925 | |
| 0.086 | 0.097 | 0.104 | Adenylate kinase inhibitor | 0.104 0.061 CID_9881925 | CID_9881925 | |
| 0.192 | 0.204 | 0.428 | Interleukin 2 agonist | 0.249 0.119 CID_9816910 0.428 0.02 CID_9881925 0.213 0.168 CID_154699717 | CID_9881925 | |
| 0.068 | 0.081 | 0.092 | Androgen antagonist | 0.092 0.053 CID_9816910 | CID_9816910 | |
| 0.067 | 0.082 | 0.082 | GABA B receptor agonist | 0.082 0.037 CID_9816910 | CID_9816910 | |
| 0.066 | 0.083 | 0.094 | Opioid kappa receptor antagonist | 0.094 0.041 CID_9816910 | CID_9816910 | |
| 0.082 | 0.099 | 0.118 | Carbonic anhydrase XV inhibitor | 0.1 0.067 CID_9816910 0.118 0.048 CID_9881925 | CID_9881925 | |
| 0.043 | 0.061 | 0.053 | Leukotriene B4 antagonist | 0.051 0.043 CID_9816910 0.053 0.039 CID_9881925 | CID_9881925 | |
| 0.092 | 0.11 | 0.123 | Cyclooxygenase 1 inhibitor | 0.123 0.077 CID_9816910 | CID_9816910 | |
| 0.093 | 0.112 | 0.173 | Alpha-N-acetylglucosaminidase inhibitor | 0.173 0.044 CID_9881925 0.11 0.089 CID_154699717 | CID_9881925 | |
| 0.059 | 0.078 | 0.071 | Glutamate dehydrogenase inhibitor | 0.071 0.055 CID_9881925 | CID_9881925 | |
| 0.11 | 0.13 | 0.129 | Phospholipase A2 inhibitor | 0.126 0.107 CID_9816910 0.129 0.102 CID_9881925 | CID_9881925 | |
| 0.034 | 0.054 | 0.065 | Mannosidase inhibitor | 0.065 0.014 CID_9881925 | CID_9881925 | |
| 0.072 | 0.095 | 0.088 | mTOR complex 2 inhibitor | 0.088 0.05 CID_9881925 | CID_9881925 | |
| 0.131 | 0.154 | 0.144 | Succinate dehydrogenase inhibitor | 0.138 0.136 CID_9881925 0.144 0.124 CID_154699717 | CID_154699717 | |
| 0.095 | 0.122 | 0.133 | NADPH oxidase inhibitor | 0.133 0.068 CID_9816910 | CID_9816910 | |
| 0.083 | 0.111 | 0.106 | MAO inhibitor | 0.106 0.084 CID_9816910 | CID_9816910 | |
| 0.015 | 0.043 | 0.021 | Dopamine D1 agonist | 0.021 0.018 CID_9816910 | CID_9816910 | |
| 0.07 | 0.099 | 0.088 | Transcription factor NF kappa B stimulant | 0.088 0.054 CID_9881925 | CID_9881925 | |
| 0.004 | 0.034 | 0.014 | Beta 3 adrenoreceptor agonist | 0.014 0.006 CID_9881925 | CID_9881925 | |
| 0.071 | 0.102 | 0.085 | ATPase (Vacuolar H+) inhibitor | 0.085 0.068 CID_9816910 | CID_9816910 | |
| 0.097 | 0.131 | 0.214 | Peroxidase inhibitor | 0.214 0.056 CID_9816910 | CID_9816910 | |
| 0.052 | 0.087 | 0.065 | Cathepsin G inhibitor | 0.065 0.061 CID_9881925 | CID_9881925 | |
| 0.063 | 0.101 | 0.1 | Opioid antagonist | 0.1 0.048 CID_9816910 | CID_9816910 | |
| 0.017 | 0.055 | 0.024 | Thyroid hormone agonist | 0.024 0.021 CID_9816910 | CID_9816910 | |
| 0.05 | 0.09 | 0.079 | Glutamate decarboxylase inhibitor | 0.079 0.045 CID_9816910 | CID_9816910 | |
| 0.086 | 0.127 | 0.111 | Aldehyde dehydrogenase inhibitor | 0.111 0.082 CID_9816910 | CID_9816910 | |
| 0.055 | 0.098 | 0.079 | Somatostatin 1 agonist | 0.069 0.066 CID_9816910 0.079 0.053 CID_9881925 | CID_9881925 | |
| 0.061 | 0.106 | 0.081 | MAO A inhibitor | 0.081 0.079 CID_9816910 | CID_9816910 | |
| 0.025 | 0.07 | 0.035 | Antibiotic Aminoglycoside-like | 0.033 0.03 CID_9881925 0.035 0.026 CID_154699717 | CID_154699717 | |
| 0.111 | 0.158 | 0.13 | Interferon gamma antagonist | 0.13 0.111 CID_9816910 | CID_9816910 | |
| 0.023 | 0.073 | 0.039 | Dopamine D5 agonist | 0.039 0.029 CID_9816910 | CID_9816910 | |
| 0.041 | 0.092 | 0.068 | Leukotriene antagonist | 0.068 0.042 CID_9881925 | CID_9881925 | |
| 0.074 | 0.131 | 0.155 | M18 aspartyl aminopeptidase inhibitor | 0.155 0.05 CID_9816910 | CID_9816910 | |
| 0.123 | 0.183 | 0.225 | Immunostimulant | 0.165 0.143 CID_9816910 0.225 0.107 CID_9881925 | CID_9881925 | |
| 0.12 | 0.184 | 0.15 | Phospholipase C inhibitor | 0.15 0.106 CID_9816910 0.149 0.108 CID_9881925 | CID_9816910 | |
| 0.024 | 0.089 | 0.051 | Geranyltranstransferase inhibitor | 0.051 0.021 CID_154699717 | CID_154699717 | |
| 0.122 | 0.188 | 0.139 | Neurotensin receptor agonist | 0.139 0.132 CID_9816910 | CID_9816910 | |
| 0.037 | 0.109 | 0.057 | Glucosylceramidase inhibitor | 0.057 0.035 CID_9881925 | CID_9881925 | |
| 0.06 | 0.132 | 0.09 | Creatine kinase inhibitor | 0.09 0.072 CID_9816910 | CID_9816910 | |
| 0.07 | 0.143 | 0.103 | Beta amyloid protein antagonist | 0.103 0.086 CID_154699717 | CID_154699717 | |
| 0.027 | 0.103 | 0.062 | Opioid delta receptor antagonist | 0.062 0.045 CID_9816910 | CID_9816910 | |
| 0.036 | 0.113 | 0.048 | Vanilloid 2 antagonist | 0.048 0.046 CID_9816910 | CID_9816910 | |
| 0.063 | 0.142 | 0.091 | Carbonic anhydrase III inhibitor | 0.091 0.073 CID_9816910 0.086 0.08 CID_9881925 | CID_9816910 | |
| 0.032 | 0.111 | 0.068 | Phosphofructokinase-1 inhibitor | 0.068 0.049 CID_9881925 | CID_9881925 | |
| 0.056 | 0.135 | 0.101 | HIV-1 integrase (Overall Integration) inhibitor | 0.101 0.053 CID_9881925 | CID_9881925 | |
| 0.031 | 0.112 | 0.064 | Opioid mu receptor antagonist | 0.064 0.05 CID_9816910 | CID_9816910 | |
| 0.06 | 0.143 | 0.079 | NADH dehydrogenase inhibitor | 0.079 0.076 CID_9881925 | CID_9881925 | |
| 0.076 | 0.16 | 0.118 | Toll-Like receptor 2 antagonist | 0.118 0.08 CID_9816910 0.108 0.093 CID_9881925 | CID_9816910 | |
| 0.108 | 0.194 | 0.138 | Non-steroidal antiinflammatory agent | 0.138 0.133 CID_9881925 | CID_9881925 | |
| 0.139 | 0.227 | 0.233 | DNA synthesis inhibitor | 0.233 0.08 CID_9881925 | CID_9881925 | |
| 0.057 | 0.152 | 0.087 | UDP-glucose 4-epimerase inhibitor | 0.087 0.077 CID_9881925 | CID_9881925 | |
| 0.053 | 0.149 | 0.074 | Estrogen receptor alpha antagonist | 0.074 0.06 CID_9816910 | CID_9816910 | |
| 0.129 | 0.228 | 0.168 | Superoxide dismutase inhibitor | 0.168 0.158 CID_9816910 | CID_9816910 | |
| 0.082 | 0.189 | 0.196 | Amyloid beta aggregation inhibitor | 0.196 0.08 CID_9816910 | CID_9816910 | |
| 0.07 | 0.179 | 0.093 | Folate antagonist | 0.093 0.081 CID_154699717 | CID_154699717 | |
| 0.038 | 0.17 | 0.093 | Monophenol monooxygenase inhibitor | 0.093 0.082 CID_9816910 | CID_9816910 | |
| 0.084 | 0.224 | 0.147 | Nitric oxide antagonist | 0.135 0.111 CID_9816910 0.134 0.113 CID_9881925 0.147 0.098 CID_154699717 | CID_154699717 | |
| 0.059 | 0.201 | 0.153 | Lipid peroxidase inhibitor | 0.153 0.066 CID_9816910 | CID_9816910 | |
| 0.085 | 0.228 | 0.134 | Hepatoprotectant | 0.134 0.128 CID_9881925 | CID_9881925 | |
| 0.169 | 0.323 | 0.277 | Apoptosis agonist | 0.277 0.189 CID_9816910 | CID_9816910 | |
| 0.095 | 0.264 | 0.239 | Antioxidant | 0.239 0.09 CID_9816910 | CID_9816910 | |
| 0.024 | 0.198 | 0.082 | Histidine decarboxylase inhibitor | 0.082 0.041 CID_9881925 | CID_9881925 | |
| 0.061 | 0.244 | 0.123 | Interleukin 4 antagonist | 0.123 0.081 CID_9816910 | CID_9816910 | |
| 0.043 | 0.226 | 0.096 | Chelator | 0.096 0.084 CID_9816910 | CID_9816910 | |
| 0.057 | 0.241 | 0.13 | Estrogen antagonist | 0.13 0.039 CID_9816910 | CID_9816910 | |
| 0.06 | 0.278 | 0.137 | MAP3K9 inhibitor | 0.137 0.082 CID_9881925 | CID_9881925 | |
| 0.031 | 0.259 | 0.083 | Adenine nucleotide translocase inhibitor | 0.083 0.008 CID_9881925 | CID_9881925 | |
| 0.093 | 0.323 | 0.179 | Growth factor agonist | 0.179 0.088 CID_9881925 | CID_9881925 | |
| 0.115 | 0.365 | 0.22 | Antibacterial | 0.22 0.207 CID_154699717 | CID_154699717 | |
| 0.046 | 0.309 | 0.176 | Angiogenesis stimulant | 0.176 0.107 CID_9881925 | CID_9881925 | |
| 0.063 | 0.327 | 0.208 | Free radical scavenger | 0.208 0.091 CID_9816910 | CID_9816910 | |
| 0.036 | 0.309 | 0.112 | Estrogen receptor beta antagonist | 0.112 0.042 CID_9816910 | CID_9816910 | |
| 0.009 | 0.385 | 0.092 | HIV-1 integrase (3'-Processing) inhibitor | 0.092 0.029 CID_154699717 | CID_154699717 | |
| 0.11 | 0.5 | 0.279 | Antiinflammatory | 0.279 0.235 CID_154699717 | CID_154699717 | |
| 0.007 | 0.4 | 0.086 | HIV-1 integrase (Strand Transfer) inhibitor | 0.086 0.028 CID_154699717 | CID_154699717 | |
| 0.016 | 0.419 | 0.069 | HIV-1 integrase inhibitor | 0.069 0.049 CID_154699717 | CID_154699717 | |
| 0.03 | 0.712 | 0.461 | Immunomodulator | 0.461 0.029 CID_154699717 | CID_154699717 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |